ELLIPTA: Clinical Trials

3 trials of ELLIPTA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Active not recruiting 1

Follow ELLIPTA: new trials by email Literature Review of ELLIPTA trials Research Report on ELLIPTA

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
FF/UMEC/VI, ELLIPTA, FF/VI - Asthma
Phase 3Active not recruitingGlaxoSmithKline1382023-04-242026-11-04
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
FF/VI, FF/UMEC/VI, ELLIPTA - Asthma
Phase 3CompletedGlaxoSmithKline3592021-07-292025-08-11
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
ELLIPTA, DISKUS - Pulmonary Disease, Chronic Obstructive
Phase 3CompletedGlaxoSmithKline2872013-05-012014-03-04

Conditions studied

Asthma (2)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

GlaxoSmithKline (3)

Countries

United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  China (1)  ·  Israel (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 26516724